Evidence map›Paper›PMID 33938235›Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2021

Loss of growth hormone signaling in the mouse germline or in adulthood reduces islet mass and alters islet function with notable sex differences.

Silvana Duran-Ortiz, Kathryn L Corbin, Ishrat Jahan, Nicholas B Whitticar, Sarah E Morris, Ania N Bartholomew, Kira G Slepchenko, Hannah L West, Ibiagbani Mercy Max Harry, Edward O List and 2 more

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Silvana Duran-OrtizEdison Biotechnology Institute, Ohio University, Athens, Ohio.
Kathryn L CorbinDepartment of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio.
Ishrat JahanDepartment of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio.
Nicholas B WhitticarDepartment of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio.
Sarah E MorrisDepartment of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio.
Ania N BartholomewDepartment of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio.
Kira G SlepchenkoDepartment of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio.
Hannah L WestDepartment of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio.
Ibiagbani Mercy Max HarryDepartment of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio.
Edward O ListEdison Biotechnology Institute, Ohio University, Athens, Ohio.
John J KopchickEdison Biotechnology Institute, Ohio University, Athens, Ohio.
Craig S NunemakerDepartment of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio.ORCID 0000-0003-2894-3388
Ohio University · USBiotechnology Institute · US

Funding

Coordinating and Bioinformatics Unit for the MMPC/DiaCompU24DK076169 · NIDDK · AUGUSTA UNIVERSITY · PI MCINDOE, RICHARD A. · 2006 to 2018
$42.4M
Modulating Growth Hormone Action as a Target for Improved Health and LongevityR01AG059779 · NIA · OHIO UNIVERSITY ATHENS · PI John Joseph Kopchick · 2018 to 2026
$4.7M
HHS | National Institutes of Health (NIH) AG059779HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) DK076169NIA NIH HHS R01 AG059779NIDDK NIH HHS U24 DK076169
6 · The paper itself

Abstract

In the endocrine pancreas, growth hormone (GH) is known to promote pancreatic islet growth and insulin secretion. In this study, we show that GH receptor (GHR) loss in the germline and in adulthood impacts islet mass in general but more profoundly in male mice. GHR knockout (GHRKO) mice have enhanced insulin sensitivity and low circulating insulin. We show that the total cross-sectional area of isolated islets (estimated islet mass) was reduced by 72% in male but by only 29% in female GHRKO mice compared with wild-type controls. Also, islets from GHRKO mice secreted ∼50% less glucose-stimulated insulin compared with size-matched islets from wild-type mice. We next used mice with a floxed

Indexed as

Age FactorsAnimalsCell ProliferationFemaleGerm CellsGrowth HormoneIslets of LangerhansMaleMiceMice, Inbred C57BLMice, KnockoutOrgan SizeReceptors, SomatotropinSex CharacteristicsSignal TransductionGrowth HormoneReceptors, Somatotropincalciumgrowth hormoneinsulinislet masssex dimorphismsex specific

Identifiers

PMID33938235
PMCPMC8285598
OpenAlexW3159243564

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.